Skip to the page

Data / Form D filings / Sora Neuroscience, Inc.

Sora Neuroscience, Inc.: Form D filings

Sora Neuroscience, Inc., a health care company in Minneapolis, MN, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on November 20, 2024, reports $1.4 million sold of a $2 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4406 Beard Avenue South, Suite UL2, Minneapolis, MN, 55410
Phone
(612) 226-2508
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1882130

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 20, 2024Amendment$2,000,000$1,427,500$572,50020Oct 16, 2023sec.gov
Oct 31, 2023New notice$2,000,000$737,500$1,262,50017Oct 16, 2023sec.gov
Sep 9, 2021New notice$2,500,000$1,980,000$520,00021Aug 23, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ann R. SennDirector
Stephen R. SchaeferExecutive Officer, Director, Promoter
Tara R. ButlerDirector
Daniel R. MarcusDirector
Eric R. LeuthardtDirector

Other health care companies in Minnesota that filed recently

Every Form D from the week of Nov 18, 2024 · All recent filings in Minnesota · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Sora Neuroscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.